未登录

L

Lucie Benešová

motol university hospital

H指数:22

被引数:1,201

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS)- A Helicobacter-opposite point

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY

IF4

2021-03-0117

OAAI

Prediction of long-term effect of anti-angiogenic therapy in lung cancer patients by monitoring early changes in circulating-tumor DNA (ctDNA)

EUROPEAN RESPIRATORY JOURNAL

IF21

2020-10-280

PRE

Application of oncoMonitor™ ctDNA tracking technology for monitoring of therapy and early detection of recurrence in metastatic colorectal cancer

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response

监测新辅助同步放化疗的直肠癌患者血浆中循环肿瘤DNA的早期变化: 评估预后和预测治疗反应

FRONTIERS IN ONCOLOGY

IF3.3

2020-07-2432

OAAI

Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA

循环肿瘤DNA在转移性结直肠癌患者术后随访中的意义

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2019-12-2824

OAAI

Application of a serial liquid biopsy ctDNA assay for monitoring efficacy of anti-angiogenic lung cancer therapy

CANCER RESEARCH

IF16.6

2019-07-010

PRE

Using a ctDNA liquid biopsy assay for post-surgical serial monitoring and early detection of disease progression in advanced colorectal cancer patients

CANCER RESEARCH

IF16.6

2019-07-010

PRE

Profiles of somatic mutations in tissue of IBD and IBD-associated carcinomas revealed by a targeted next-generation sequencing (NGS) tumour panel confirm notable differences from sporadic colorectal carcinomas

JOURNAL OF CROHNS & COLITIS

IF8.7

2019-01-250

OAAI

Molecular phenotyping of colorectal tumors in clinical practice: Assignment of extended prognostic subtypes by direct testing of endoscopic specimens

CANCER RESEARCH

IF16.6

2017-01-310

PRE

The significance of postoperative follow-up of patients with advanced colorectal cancer using circulating tumor DNA: Selected case studies

CANCER RESEARCH

IF16.6

2017-01-310

PRE

Fundamental significance of specific KRAS mutant types for prognosis of unresectable pancreatic cancer patients

CANCER RESEARCH

IF16.6

2016-12-140

PRE

Molecular cancer testing of KRAS and miR-21 from EUS-guided biopsies of pancreatic tissue: Utility of aspirates vs. cytology

CANCER RESEARCH

IF16.6

2016-12-140

PRE

The first European family with gastric adenocarcinoma and proximal polyposis of the stomach: case report and review of the literature

GASTROINTESTINAL ENDOSCOPY

IF7.5

2016-10-0142

PREAI

Detection of specific KRAS mutation type, Gly12Asp (GGT>GAT), in EUS-guided fine needle aspiration cytology (EUS-FNAC) identifies pancreatic cancer patients with poor prognosis

CANCER RESEARCH

IF16.6

2016-07-151

PRE

Liquid biopsy (ctDNA) testing in clinical management of solid cancers: 5-years of experience

CANCER RESEARCH

IF16.6

2016-07-150

PRE

Prospective Longitudinal Molecular Characterization of Colorectal Tumors Based on CIMP/MSI/BRAF/KRAS Classification: Comparison of Advanced Adenomas to Early and Late Carcinomas

GASTROENTEROLOGY

IF25.1

2016-04-010

PREAI

KRAS Mutation Assay on EUS FNA Specimens From Pacients With Pancreatic Mass

GASTROENTEROLOGY

IF25.1

2016-04-010

PREAI

Longitudinal molecular characterization of endoscopic specimens from colorectal lesions

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2016-01-019

OA

Monitoring minimal residual disease by urinary or plasma circulating tumor DNA of KRAS mutation burden in colorectal cancer patients with resectable liver metastases

CANCER RESEARCH

IF16.6

2015-08-010

PRE

Validation of a simple low-cost method to monitor ctDNA in patients with solid cancers

CANCER RESEARCH

IF16.6

2015-08-010

PRE